Hone DM, Tacket CO, Harris AM, Kay B, Losonsky G, Levine MM: Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 1992,90(2):412–420.PubMedCrossRef 31. Dilts DA, Riesenfeld-Orn I, Fulginiti JP, Ekwall E, Granert C, Nonenmacher J, Brey RN, Cryz SJ, Karlsson K, Bergman K, et al.: Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine 2000,18(15):1473–1484.PubMedCrossRef 32. Kotton CN, Lankowski AJ, Scott N, Sisul D, Chen LM, Raschke K, Borders G, Boaz M, Spentzou A, Galan JE, et al.: Safety

and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering

an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine 2006,24(37–39):6216–6224.PubMedCrossRef 33. Kwon YM, AZD1152 cost Cox MM, Calhoun LN: Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines 2007,6(2):147–152.PubMedCrossRef 34. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, Van Maele L, Sirard JC, Mueller AJ, Heikenwalder M, et al.: The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 2010,6(9):e1001097.PubMedCrossRef 35. Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, Holden DW: Simultaneous identification of bacterial virulence genes by negative selection. see more Science 1995,269(5222):400–403.PubMedCrossRef 36. Shea JE, Beuzon CR, Gleeson C, Mundy R, Holden

DW: Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse. Infect Immun 1999,67(1):213–219.PubMed 37. Periaswamy B, Maier L, Vishwakarma V, Slack E, Kremer M, Andrews-Polymenis HL, McClelland M, Grant AJ, Suar M, Hardt WD: Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice. PLoS One 2012,7(9):e45433.PubMedCrossRef 38. Fang FC: Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004,2(10):820–832.PubMedCrossRef next 39. Valdivia RH, Cirillo DM, Lee AK, Bouley DM, Falkow S: mig-14 is a horizontally acquired, host-induced gene required for salmonella enterica lethal infection in the murine model of typhoid fever. Infect Immun 2000,68(12):7126–7131.PubMedCrossRef 40. Brodsky IE, Ghori N, Falkow S, Monack D: Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol 2005,55(3):954–972.PubMedCrossRef 41. Hoiseth SK, Stocker BA: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981,291(5812):238–239.PubMedCrossRef 42.